Jan. 27 at 2:59 PM
INVO Fertility announced that shareholders approved a significant increase in authorized common stock, raising the number of authorized shares from 6.25 million to 250 million at a special meeting held on January 22, 2026. Following approval, the company filed a Certificate of Amendment to implement the change.
Shareholders also approved several additional proposals, including the ratification of WithumSmith+Brown, PC as independent auditor for fiscal 2025, the issuance of up to 4,733,728 common shares upon exercise of warrants from a private placement completed on December 4, 2025, and a fourth amendment to the 2019 Equity Incentive Plan, increasing shares available for issuance to 1.0 million, or about 10% of fully diluted shares outstanding.
A total of 944,054 common shares were represented at the meeting, constituting a quorum. The proposal to increase authorized common stock passed with 663,861 votes in favor, 279,474 against, and 719 abstentions.
$INVO